Cargando…
Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
Autores principales: | Ferrucci, PF, Rabascio, C, Corsini, C, Tealdo, F, Paolucci, M, Bertolini, F, El Taani, H, Martinelli, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300870/ http://dx.doi.org/10.1186/bcr172 |
Ejemplares similares
-
In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells
por: Hassan, Eman M., et al.
Publicado: (2017) -
Evaluation of Serum Mammaglobin as an Alternative Biomarker in the Diagnosis of Breast Tumors
por: Fatima, Maira, et al.
Publicado: (2022) -
Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016) -
The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma
por: Milosevic, Bojan, et al.
Publicado: (2023) -
Characterization of GATA3 and Mammaglobin in breast tumors from African American women
por: Ricks-Santi, Luisel J., et al.
Publicado: (2023)